SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Far below the surface, where light no longer reaches and noise collapses into silence, the Sperm Whale endures.  It does not rely on speed or spectacle. It survives through mass, intelligence, and absolute awareness of its surroundings.  This project is shaped by the same principle — strength formed under pressure, movement guided by understanding, and conviction built where others cannot remain.  While the surface reacts, the deep decides.

The Sperm Whale

SPERMWHALE is trending as the community rallies behind its meme status, with enthusiasts actively debating its potential to reclaim peak levels and lose more zeros despite significant volatility. Discussion remains polarized, as proponents push for further accumulation while others warn of the risks inherent in such speculative, low-market-cap assets.

eBay, Inc. is a commerce company, whose platforms include an online marketplace and its localized counterparts, including off-platform businesses in South Korea, Japan, and Turkey, as well as eBay’s suite of mobile apps. It offers a platform for various product categories, including parts and accessories, collectibles, fashion, electronics, and home & garden. eBay generates revenue mainly through fees from sales, payment processing, and advertising. The company was founded by Pierre Morad Omidyar in September 1995 and is headquartered in San Jose, CA.

EBay Inc.

eBay Inc

eBay is trending following a Wall Street Journal report that GameStop is preparing a takeover bid, fueling massive speculation about how a significantly smaller retailer could finance such a large-scale acquisition. Community members are actively debating the feasibility of the deal, with many skeptical of the math while others analyze potential synergy in collectibles and e-commerce infrastructure.

NANO Nuclear Energy, Inc. is a microreactor and nuclear technology company, which provides supply energy services. Its products in technical development are ZEUS, a solid core battery reactor, and ODIN, a low-pressure coolant reactor. The company is founded by Jiang Yu in February, 2022 and is headquartered in New York, NY.

Nano Nuclear Energy Inc.

Nano Nuclear Energy is attracting significant attention as investors speculate on the Small Modular Reactor (SMR) market, with the stock seeing increased volume as community members debate its potential to meet energy demands for AI data centers. Sentiment remains mixed, characterized by active discussions around technical setup, speculative short-squeeze potential, and the broader regulatory environment for advanced nuclear power.

Terrestrial Energy, Inc. is an advanced nuclear technology company focused on next-generation nuclear energy systems. The company is developing the Integral Molten Salt Reactor (IMSR), an innovative type of Generation IV molten salt reactor designed to produce reliable, low-carbon heat and electricity at competitive costs. The company is headquartered in Charlotte, NC.

Terrestrial Energy Inc.

IMSR is attracting significant community attention as investors track its shift toward more efficient regulatory pathways and potential project milestones, viewing it as a long-term play in the expanding energy demand sector. Discussion centers on the companys recent technical documentation submissions and its role in supplying power for AI data centers, with many participants advocating for a patient, multi-year holding strategy despite recent price volatility.

Cameco Corp. engages in the provision of uranium. It operates through the Uranium and Fuel Services segments. The Uranium segment is involved in the exploration for, mining, milling, purchase, and sale of uranium concentrate. The Fuel Services segment deals with the refining, conversion, and fabrication of uranium concentrate and the purchase and sale of conversion services. The company was founded in 1988 and is headquartered in Saskatoon, Canada.

Cameco Corp.

Cameco Corp is trending as investors monitor nuclear energy's critical role in meeting the massive power demands of AI data centers and broader infrastructure projects. Community sentiment remains focused on long-term supply constraints and the sector's strategic importance, with active discussions tracking contract developments and the long-term outlook for uranium demand.

Terra is a decentralized financial payment network that rebuilds the traditional payment stack on the blockchain. Luna is the reserve currency of the Terra platform. It has three core functions: i) mine Terra transactions through staking, ii) ensure the price stability of Terra stablecoins and iii) provide incentives for the platform’s blockchain validators.

Terra Luna Classic

Terra Luna Classic is trending as a segment of the community remains highly bullish, pointing toward active token burns, anticipated ecosystem project launches, and potential long-term price recovery. While some investors advocate for holding in hopes of a major supply shock, others are actively debating the token's future utility and the historical context of its market performance.

The Ondo Foundation was founded in 2022 as an independently governed and nonprofit Cayman Islands Foundation Company with no beneficial owners. The Ondo Foundation assisted in the launch of the Ondo DAO, which deployed and currently governs Flux Finance, the first lending protocol supporting tokenized securities as collateral.  ONDO token holders are entrusted with shaping the future of the Ondo DAO so that it continues to pursue its mission to democratize access to institutional-grade finance. The Ondo DAO gives ONDO holders specific rights pertaining to Flux Finance, which is currently governed by the Ondo DAO.

Ondo

Ondo is trending as the community debates its role as an institutional-grade RWA infrastructure play, balancing enthusiasm for partnerships with firms like BlackRock and Franklin Templeton against concerns regarding upcoming token unlocks and price stagnation. Investors are actively discussing the platform's potential to bridge traditional finance with on-chain liquidity, with many navigating a mix of long-term conviction in its real-world utility and frustration over short-term market performance.

Alpha Tau Medical Ltd. is a clinical-stage oncology therapeutics company, which focuses on the research, development, and commercialization of diffusing alpha-emitters radiation therapy for the treatment of cancer. The firm is involved in the clinical trials at cancer centers with indications that include skin cancer, oral cavity cancer, breast cancer, and pancreatic cancer. The company was founded by Uzi Sofer, Yona Keisari, and Itzhak Kelson in November 2015 and is headquartered in Jerusalem, Israel.

Alpha Tau Medical Ltd

ALPHA TAU MEDICAL LTD

Alpha Tau Medical is trending as investors anticipate upcoming pancreatic cancer data at the Digestive Disease Week conference, driving momentum and active discussion regarding the stock's clinical potential and future valuation.

NuScale Power Corp. provides proprietary and innovative advanced small modular reactor (SMR) nuclear technology, with a mission to help power the global energy transition by delivering safe, scalable, and reliable carbon-free energy. Its products include VOYGR SMR Plants and Energy Exploration (E2) Centers. The company was founded by José N. Reyes in 2007 and is headquartered in Corvallis, OR.

NuScale Power Corporation - Ordinary Shares - Class A

NuScale Power Corp

NuScale Power is attracting intense attention following a federal initiative to accelerate the deployment of nuclear reactors in space, which has reinvigorated the bull case for small modular reactor technology. The stock is seeing massive trading volume and heightened community discussion as traders debate its potential for a short-term squeeze and long-term role in meeting the surging power demands of AI data centers.

Citigroup Global Markets Holdings, Inc. provides investment banking and securities brokerage services. It offers financial advisory, research and capital raising services to corporations, governments and individuals. The company was founded in 1977 and is headquartered in New York, NY.

Citigroup Inc

Citigroup Inc. (C) is currently trending as a prominent large-cap bank play, fueled by institutional momentum and positive sentiment surrounding the company's multi-year strategic transformation, cost-cutting initiatives, and capital optimization efforts. The stock has gained significant investor attention as it achieves new 52-week highs, with the community actively discussing Citigroup's role as a top-tier financial pick alongside peers like JPMorgan and Goldman Sachs, while closely monitoring upcoming earnings and the potential for increased shareholder returns.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Wall Street Zen Downgrades Dyne Therapeutics (NASDAQ:DYN) to Strong Sell

Wall Street Zen lowered shares of Dyne Therapeutics from a "sell" rating to a "strong sell" rating in a report on Saturday...

Insider Selling: Dyne Therapeutics (NASDAQ:DYN) Director Sells 227,337 Shares of Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Jason Rhodes sold 227,337 shares of the company's stock in a transaction on Tuesday, April 28th. The shares were sold at an average...

Jason Rhodes Sells 73,108 Shares of Dyne Therapeutics (NASDAQ:DYN) Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Jason Rhodes sold 73,108 shares of the stock in a transaction on Thursday, April 23rd. The shares were sold at an average price of...

Dyne Therapeutics (NASDAQ:DYN) Director Sells $1,402,942.52 in Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Jason Rhodes sold 73,108 shares of the firm's stock in a transaction on Thursday, April 23rd. The stock was sold at an average price of...

Dyne Therapeutics (NASDAQ:DYN) Director Sells $3,148,897.95 in Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Jason Rhodes sold 173,493 shares of Dyne Therapeutics stock in a transaction dated Monday, April 27th. The stock was sold at an average...

Jason Rhodes Sells 137,948 Shares of Dyne Therapeutics (NASDAQ:DYN) Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Jason Rhodes sold 137,948 shares of the stock in a transaction dated Friday, April 24th. The stock was sold at an average price of...

Dyne Therapeutics (NASDAQ:DYN) Director Jason Rhodes Sells 287,956 Shares

Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Jason Rhodes sold 287,956 shares of the firm's stock in a transaction dated Wednesday, April 22nd. The shares were sold at an average...

Jason Rhodes Sells 274,297 Shares of Dyne Therapeutics (NASDAQ:DYN) Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Jason Rhodes sold 274,297 shares of the business's stock in a transaction that occurred on Tuesday, April 21st. The shares were sold at...

Dyne Therapeutics (NASDAQ:DYN) Director Jason Rhodes Sells 272,049 Shares of Stock

Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) Director Jason Rhodes sold 272,049 shares of the company's stock in a transaction that occurred on Monday, April 20th. The shares were sold at...

Dyne Therapeutics, Inc. (NASDAQ:DYN) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Shares of Dyne Therapeutics, Inc. (NASDAQ:DYN - Get Free Report) have been assigned a consensus recommendation of "Moderate Buy" from the seventeen research firms that are currently covering the...

Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. It develops a broad portfolio of therapeutics for muscle diseases, including lead programs in myotonic dystrophy type 1, Duchenne muscular dystrophy, and facioscapulohumeral muscular dystrophy. The company was founded by Jason P. Rhodes and Romesh R. Subramanian on December 1, 2017 and is headquartered in Waltham, MA.

Current Price	$17.39
Prev Close	$17.55
Open	$17.46
Dividend Yield	0.00%
50-Day Moving Average	$17.86
Beta	1.87
Avg. Volume	1.75M
PE Ratio	-4.91

52-Week High	$25.00
52-Week Low	$8.06
Market Capitalization	$2.87B
EPS (Annual)	-$3.47
Price to Book	2.95
Revenue Per Employee	$0.00

DYN
Dyne Therapeutics Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest DYN News

DYNDyne Therapeutics Inc